JAMES WELSH to CTLA-4 Antigen
This is a "connection" page, showing publications JAMES WELSH has written about CTLA-4 Antigen.
Connection Strength
0.537
-
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials. J Immunother Cancer. 2020 Jan; 8(1).
Score: 0.509
-
Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol. 2017 10; 125(1):80-88.
Score: 0.027